Discontinued — last reported Q3 '22
Anatomic pathology testing services — Net revenues
Quest Diagnostics Anatomic pathology testing services — Net revenues increased by 3.5% to $149.00M in Q3 2022 compared to the prior quarter. Year-over-year, this metric grew by 8.0%, from $138.00M to $149.00M. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates growth in testing volume or pricing power within the pathology segment, while a decrease suggests potential loss of market share or reduced demand for specialized diagnostic procedures.
Detailed definition
This metric tracks the total net revenue generated from anatomic pathology testing, which involves the examination of su...
Peer comparison
Most large-scale diagnostic laboratory companies disclose revenue by service line, making this comparable to specialized testing revenue segments at other major clinical lab providers.
dgx_segment_anatomic_pathology_testing_services_net_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | |
|---|---|---|---|---|---|---|
| Value | $140.00M | $138.00M | $145.00M | $137.00M | $144.00M | $149.00M |
| QoQ Change | — | -1.4% | +5.1% | -5.5% | +5.1% | +3.5% |
| YoY Change | — | — | — | — | +2.9% | +8.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Quest Diagnostics's anatomic pathology testing services — net revenues?
- Quest Diagnostics (DGX) reported anatomic pathology testing services — net revenues of $149.00M in Q3 2022.
- How has Quest Diagnostics's anatomic pathology testing services — net revenues changed year-over-year?
- Quest Diagnostics's anatomic pathology testing services — net revenues increased by 8.0% year-over-year, from $138.00M to $149.00M.
- What does anatomic pathology testing services — net revenues mean?
- The total dollar amount of revenue earned from providing anatomic pathology diagnostic services.